For instance, approximately 30%–50% of colorectal cancer tumors have a mutated KRAS gene,80 whereas it has been observed to be mutated in 90% of pancreatic cancers of all grades,81 and the mutation signatures differ between them as well. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.